← Leaderboards
Elena Goncharova
Boston University Medical Campus
$9,715,004
Attributed
$11,471,551
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,471,551 · 5
By mechanism
R01$10,533,797 · 4
T32$937,754 · 1
Top collaborators
- Maria Trojanowska4 shared
- Nicholas J Kenyon2 shared
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Adeline Marie Matschulat$169,651
- Maria Trojanowska$16,742,564
- Joseph Kern$181,096
- Rachel Xi-Yeen Ho$98,512
- Maria Isabel Ramirez$8,403,076
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungInsightSignal TransductionPublishingResistancePulmonary Arterial HypertensionPathogenesisCessation Of LifeApoptosisCellsMolecularSmooth Muscle MyocytesGrowthStructure Of Parenchyma Of LungMolecular TargetTherapeutic InterventionAttenuatedDisease ProgressionPhenotypeBaseCell SurvivalIn VitroReportingLink
Grant awards (26)
LDHA-lactate signaling in pulmonary arterial hypertension$653,442
R01 · FY2025 · HL · contact PI
Training in Comparative Lung Biology and Medicine$401,116
T32 · FY2025 · HL · contact PI
LDHA-lactate signaling in pulmonary arterial hypertension$681,551
R01 · FY2024 · HL · contact PI
Training in Comparative Lung Biology and Medicine$536,638
T32 · FY2024 · HL
GATA-6 in pulmonary arterial hypertension$632,908
R01 · FY2023 · HL
HIPPO Signaling in Pulmonary Arterial Hypertension$492,072
R01 · FY2023 · HL · contact PI
GATA-6 in pulmonary arterial hypertension$637,597
R01 · FY2022 · HL
HIPPO Signaling in Pulmonary Arterial Hypertension$492,506
R01 · FY2022 · HL · contact PI
GATA-6 in pulmonary arterial hypertension$641,192
R01 · FY2021 · HL
HIPPO Signaling in Pulmonary Arterial Hypertension$492,779
R01 · FY2021 · HL · contact PI
TSC2 Signaling in Pulmonary Arterial Hypertension$397,063
R01 · FY2021 · HL · contact PI
GATA-6 in pulmonary arterial hypertension$663,643
R01 · FY2020 · HL
HIPPO Signaling in Pulmonary Arterial Hypertension$428,302
R01 · FY2020 · HL · contact PI
TSC2 Signaling in Pulmonary Arterial Hypertension$370,269
R01 · FY2020 · HL · contact PI
HIPPO signaling in Pulmonary Arterial Hypertension$77,413
R01 · FY2020 · HL · contact PI
TSC2 signaling in Pulmonary Arterial Hypertension$25,313
R01 · FY2020 · HL · contact PI
TSC2 signaling in Pulmonary Arterial Hypertension$395,582
R01 · FY2019 · HL · contact PI
HIPPO signaling in Pulmonary Arterial Hypertension$386,408
R01 · FY2019 · HL · contact PI
TSC2 signaling in Pulmonary Arterial Hypertension$409,071
R01 · FY2018 · HL · contact PI
HIPPO signaling in Pulmonary Arterial Hypertension$386,397
R01 · FY2018 · HL · contact PI
HIPPO signaling in Pulmonary Arterial Hypertension$386,387
R01 · FY2017 · HL · contact PI
HIPPO signaling in Pulmonary Arterial Hypertension$399,877
R01 · FY2016 · HL · contact PI
mTOR coordinates cell metabolism, growth and survival in pulmonary hypertension$367,145
R01 · FY2015 · HL · contact PI
mTOR coordinates cell metabolism, growth and survival in pulmonary hypertension$365,282
R01 · FY2014 · HL · contact PI
mTOR coordinates cell metabolism, growth and survival in pulmonary hypertension$351,598
R01 · FY2013 · HL · contact PI
mTOR coordinates cell metabolism, growth and survival in pulmonary hypertension$400,000
R01 · FY2012 · HL · contact PI